Infinity Pharmaceuticals | INFI - سرمایه عادی





سرمایه عادی تغییر دادن تاریخ
AbbVie USD 1.77B 1.75B 2025-06
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Infinity Pharmaceuticals USD 90K 1000 2023-06
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
J&J USD 2.41B 1.74M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Plus Therapeutics USD 138.68M 7.07M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09